STOCK TITAN

Derek Maetzold sells shares; CSTL (NASDAQ: CSTL) Form 144 lists large late‑2025 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CSTL filing: Notice of proposed sales of Common Stock by reporting person Derek Maetzold

The filing lists multiple dispositions of Common stock by Derek Maetzold under a Form 144 notice, describing sales executed on various dates and securities acquired by gift and compensation (RSUs, PSUs, options). Several transactions in late 2025 and early 2026 are itemized with share counts and proceeds.

Positive

  • None.

Negative

  • None.

Insights

Routine registered sales by an insider with multiple earlier compensation grants and gift acquisitions.

The excerpt lists numerous sales by Derek Maetzold, including large executions such as $651,278.06 for 12/15/2025 (16,847 shares) and $493,526.45 for 12/16/2025 (12,821 shares). The record also shows compensation grants (RSUs, PSUs) dated 03/03/202603/04/2026 and earlier option-related activity.

These entries document transactional activity rather than new corporate actions; cash‑flow recipients are the selling holder. Subsequent public filings may provide fuller position context and whether sales were pre‑arranged.

Form 144 notice format and multiple dated dispositions consistent with Rule 144 reporting.

The content itemizes dates, share counts, and gross proceeds for sales, and lists acquisition sources (gift, compensation, option exercise). The filing format aligns with a registered sale notice under securities resale rules.

Compliance implication: confirm any Rule 144 holding‑period and public‑information conditions in related filings; timing and method details may appear in accompanying broker records or Form 4/5 filings.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CSTL's Form 144 from Derek Maetzold report?

The Form 144 reports proposed or effected sales of Common stock by Derek Maetzold, listing sale dates, share counts, and gross proceeds. It also lists acquisition sources such as gifts, Restricted Stock Units, Performance Stock Units, and option exercises as recorded in the filing.

How many shares and proceeds are shown for recent large transactions?

The excerpt shows several large dispositions, for example 16,847 shares generating $651,278.06 on 12/15/2025 and 12,821 shares generating $493,526.45 on 12/16/2025. These are listed as individual sale entries with gross proceeds.

Does the filing state why Mr. Maetzold sold shares?

The filing lists acquisition sources (gift, compensation, cashless exercise/same‑day sale) but does not state a personal rationale for the sales. The document confines itself to transaction details: dates, share counts, and proceeds without explanatory commentary.

Are recent share grants disclosed alongside the sales in the filing?

Yes. The excerpt records compensation‑related acquisitions including RSUs dated 03/04/2026 (e.g., 17,632 and 23,534 shares) and PSUs dated 03/03/2026 (43,176 shares), as listed under securities information.
Castle Biosciences

NASDAQ:CSTL

View CSTL Stock Overview

CSTL Rankings

CSTL Latest News

CSTL Latest SEC Filings

CSTL Stock Data

790.85M
28.40M
Diagnostics & Research
Services-medical Laboratories
Link
United States
FRIENDSWOOD